The Role of BackScattering Interferometry in the Discovery and Development of Allosteric Ligands DRUG DISCOVERY IS IN A “ BIND ”

  • A “BIND
  • Published 2014
Back-Scattering Interferometry (BSI) is an emerging label-free conformation-sensitive technology that fills a vital need in discovery and development of pharmaceuticals in the highly valuable “allosteric” space. The drug development process is increasingly frustrated by the search for compounds that bind to the same sites as existing drugs or natural… CONTINUE READING